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The biologic role of a majority of the Neisseria meningitidis 2100 predicted coding regions is still to be assigned or
experimentally confirmed. Determining the phenotypic effect of gene disruption being a fundamental approach
to understanding gene function, we used high-density signature-tagged transposon mutagenesis, followed by a
large-scale sequencing of the transposon insertion sites, to construct a genome-wide collection of mutants. The
sequencing results for the first half of the 4548 mutants composing the library suggested that we have
mutations in 80%–90% of N. meningitidis nonessential genes. This was confirmed by a whole-genome
identification of the genes required for resistance to complement-mediated lysis, a key to meningococcal
virulence. We show that all the genes we identified, including four previously uncharacterized, were important
for the synthesis of the polysialic acid capsule or the lipooligosaccharide (LOS), suggesting that these are likely
to be the only meningococcal attributes necessary for serum resistance. Our work provides a valuable and
lasting resource that may lead to a global map of gene function in N. meningitidis.
[Supplemental material is available online at www.genome.org. The following individuals kindly provided
reagents, samples, or unpublished information as indicated in the paper: E. Carbonnelle, M. Joussemet, D.
Caugant, M.-J. Quentin-Millet.]
The ongoing accumulation of complete genome sequences in
the public databases made it clear that a genome sequencing
project is a small step in the understanding of the biology of
an organism. This can be illustrated by the example of Neis-
seria meningitidis, a human pathogen that is one of the leading
causes of fatal sepsis and meningitis worldwide (Tikhomirov
et al. 1997). The two complete meningococcal sequences con-
tain an average of 2100 predicted coding regions, of which
half were assigned no biologic role, whereas most of the re-
maining half were assigned roles that await experimental vali-
dation (Parkhill et al. 2000; Tettelin et al. 2000). The conver-
sion of these sequence data into meaningful biologic infor-
mation, by performing whole-genome experimental
investigations, is therefore an important scientific challenge.
Significant functional information can be acquired on a ge-
nome scale by analyzing, among other things, gene expres-
sion using DNA microarrays (Schena et al. 1996), protein ex-
pression using proteome chips (Zhu et al. 2001), protein sub-
cellular localization using reporter genes (Whiteley et al.
1999), or protein–protein interactions using two-hybrid tech-
nologies (Rain et al. 2001). However, as shown in the model
organism Saccharomyces cerevisiae, arguably the most direct
approach for functional genomics is the phenotypic analysis
of a collection of mutants containing mutations in each non-
essential gene (Winzeler et al. 1999). Moreover, this approach
helps in defining the minimal set of genes necessary to sup-
port cellular life as described in Mycoplasma, the sequenced
bacterium with the smallest genomic content (Hutchison et
al. 1999).
Unfortunately, the construction of an exhaustive library
of mutants is an extremely laborious process that has severely
hindered the general use of this approach. Indeed, a PCR-
mediated gene-by-gene deletion strategy is probably beyond
the scope of most individual laboratories, and is practical only
when used by international consortia as demonstrated in S.
cerevisiae (Winzeler et al. 1999). Saturating transposon muta-
genesis is an alternative approach for obtaining a genome-
wide collection of mutants. However, large libraries including
numerous mutants with transposon insertions in noncoding
regions are to be created, and the precise number of genes that
are mutagenized remains unknown. Determining the trans-
poson insertion sites in such a large number of mutants is
usually impractical, and represents the limiting step in this
approach for the rational creation of a complete library of
mutants.
Taking advantage of its small genome and tractable ge-
netics, we constructed an ordered library of 4548 signature-
tagged mutants of N. meningitidis using in vitro Himar1 mari-
ner mutagenesis (Pelicic et al. 2000). We subsequently dem-
onstrated by a large-scale determination of the insertion sites
of the transposon in half of the mutants that our library is
80%–90% complete. In addition, this was confirmed by a
functional analysis of the N. meningitidis ability to resist
complement-mediated lysis, a well-defined phenotypic trait
particularly important for its virulence (Figueroa and Densen
1991). These results validated our library as a valuable re-
source for large-scale analysis of the meningococcus genome.
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RESULTS
Creating a Genome-Wide Collection of N. meningitidis
Transposition Mutants
Bearing in mind that the overall coding density of the N.
meningitidis genome is 83% (Parkhill et al. 2000; Tettelin et al.
2000), and assuming that the selected transposon shows no
preference for coding or noncoding regions, by applying the
formula P = 1 ea/b (Walbot, 2000), where P is the probabil-
ity that a gene is mutated, a is the number of mutants in
genes, and b is the number of nonessential genes, we can
estimate that a library of 4500 transposon mutants may be
large enough to contain insertions within 92% of meningo-
coccus nonessential genes. Indeed, based on recent whole-
genome analyses of essential genes in Haemophilus influenzae
(Akerley et al. 2002) and Staphylococcus aureus (Forsyth et al.
2002), we can assume that 70% of N. meningitidis genes, 1470
out of a total of 2100, are nonessential and can therefore be
mutagenized. It should, however, be pointed out that this
prediction does not take into account the length of the genes,
which obviously influences their probability of being mu-
tated.
As recently demonstrated (Pelicic et al. 2000), in vitro
transposition of Himar1 mariner on meningococcal chromo-
somal DNA is an efficient randommutagenesis technique. We
adapted the mini-transposon for signature-tagged mutagen-
esis (STM) (Hensel et al. 1995), an effective high-throughput
screening method, by labeling it with unique identifying
DNA signature tags. This allows the presence or the absence of
individual mutants within a pool of mutants to be detected by
PCR amplification and detection of their signature tags
(Hensel et al. 1995). We used this methodology in N. menin-
gitidis 8013, a well-characterized clinical isolate, to construct
an ordered library of 4548 signature-tagged mutants that can
be analyzed in 96 pools of 44–48 mutants. Southern blot
analysis of several mutants (data not shown) demonstrated
that they harbored single transposon insertions that were dif-
ferent, in agreement with a random transposition of Himar1.
To enable the rational creation of a genome-wide library of
mutants, we prepared and ordered on microtitre plates the
chromosomal DNAs for each of the 4548 mutants of the li-
brary and started a systematic sequencing of the transposon
insertion sites. For the characterization of the genomic DNA
sequences flanking the transposon, we used a simple ligation-
mediated PCR (LMPCR) (Prod’hom et al. 1998). Here we pre-
sent the sequencing results for the first half of the library
corresponding to 2281 mutants.
We succeeded in sequencing the transposon insertion
sites in 1886 mutants or 83% of the analyzed clones (Table 1),
a success rate in accord with what was previously described for
LMPCR, demonstrating that this approach is feasible on a
large scale, in a reasonable time period. We mapped 1557
insertion sites (Table 1) using the genome sequence of N. men-
ingitidis Z2491 (Parkhill et al. 2000) and N. meningitidis MC58
(Tettelin et al. 2000). The 329 insertion sites that were not
mapped, as much as 17% of the total, were mostly in regions
that are specific to our target strain and will, therefore, be
mapped once its genome sequence will be available. This ten-
tative mapping demonstrated that transposon insertions were
scattered all around the genome (Fig. 1), including 613 differ-
ent genes, except for two large genomic regions of the Z2491
genome, which were devoid of inserted transposons. The first
one is a 38-kb region, starting at position 100000 of the Z2491
sequence, which contains mostly genes encoding ribosomal
proteins, and is therefore almost certainly essential for bacte-
rial viability. The second is a 40-kb region, starting at position
1768000 of the Z2491 sequence, which corresponds to the
prophage pnm1 known to be specific to serogroup A strains
such as Z2491 (Klee et al. 2000), and therefore absent in strain
8013. Importantly, 71% of the insertions were in genes (Table
1), a rate substantially different from the coding density of the
N. meningitidis genome, that is, 83%. This is consistent with
what was previously reported in a similar approach in the
model organism Mycoplasma (Hutchison et al. 1999), and
strengthens the idea that intergenic regions are less critical for
viability. This bias lowers somewhat the initial statistical pre-
diction to 88% of meningococcus nonessential genes being
mutated in our library, which is, nevertheless, expected to be
useful for large-scale analysis of the N. meningitidis genome.
Genome-Wide Identification of Serum-Sensitive
Mutants
To appreciate the usefulness of our resource, we identified the
genes required for resistance to complement-mediated lysis, a
key virulence attribute of N. meningitidis. We chose this phe-
notype because the polysialic acid capsule and LOS are known
to be implicated in meningococcal serum resistance (Mackin-
non et al. 1993; Kahler et al. 1998), which was expected to
help in the validation of our resource. To ensure optimal com-
parability between the results obtained in different bacteri-
cidal assays, we used a unique serum throughout this work.
This serum did not harm the wild-type strain, but killed
within minutes an unencapsulated siaA isogenic mutant
known to be serum-sensitive (Fig. 2A). This bactericidal activ-
ity was exclusively due to the action of the complement, be-
Table 1. Summary of Sequenced Transposon
Insertion Sites
Insertion sites sequenced 1886
Insertions mapped 1557
Insertions in intergenic regions 451
Insertions in genes 1106
Figure 1 Mapping of 826 sequenced transposon insertions on the
genome sequence of N. meningitidis Z2491.
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cause mutant and wild-type strains grew equally well in heat-
inactivated serum (Fig. 2B).
We screened the 96 pools of mutants in native serum in
duplicate and identified 553 serum-sensitive candidates. Such
a large number of clones, already seen in another STM analy-
sis of N. meningitidis (Sun et al. 2000), was not unexpected
because meningococcus displays a vast repertoire of genes,
often involved in virulence, which expression is controlled by
phase variation mediated through reversible changes in the
length of simple DNA repeats (Snyder et al. 2001). The phe-
notypes observed can, therefore, be due to phase variation
events in genes unlinked to transposon insertions. To exclude
this possibility, we transformed into the wild-type strain 8013
each of the 553 mutations that were selected, assembled new
pools of mutants, and tested them as above. In this second-
round of screening, we identified 159 candidates that pre-
sented reduced hybridization signals when their respective
signature tags were amplified from the bacteria recovered af-
ter passage in human serum. However, due to the inherent
limitations of the procedure used to detect the signature tags,
already pointed out in other STM studies (Camacho et al.
1999), some of these mutants were expected to correspond to
false positives, which prompted us to test them individually
in native and heat-inactivated serum. One hundred nine mu-
tants as well as the wild type resisted in native serum and
clearly represented false positives. Thirteen mutants, which
harbored transposon insertions in various housekeeping
genes and genes necessary for cell wall biosynthesis, were also
discarded because they grew poorly in heat-inactivated serum.
It is likely that these mutants were indeed underrepresented
after passage in human serum because they are less fit for
growth and are therefore out-competed when grown in pools
with other mutants. Finally, 37 mutants presented a reduced
survival in native serum but were unaffected for growth in
heat-inactivated serum, and were thus considered as serum-
sensitive (Table 2). They contained transposon insertions in
18 genes or their promoters, and two intergenic regions. For
both these latter mutants, the serum-sensitive phenotype is
likely to be due to the effect of the inserted transposon on one
of the previous 18 genes. However, the affected gene could
not be unambiguously identified as the transposon insertion
in the first mutant was in the siaA-ctrA intergenic region,
whereas it was downstream the lgtE gene in the second one.
Finally, we selected one mutant in each of the 18 genes and
determined their survival indexes, ranging from 101 to 107
(Table 2).
As mentionned above, meningococcal polysialic acid
capsule and LOS are important for serum resistance (Mackin-
non et al. 1993; Kahler et al. 1998). We were therefore not
surprised to identify mutants harboring insertions in as much
as 14 genes necessary for the biosynthesis of these two surface
molecules (Table 2). A major result of this screen was the
identification of insertions in 8 out of 10 known capsule syn-
thesis genes that are present in the cps gene cluster and are
sufficient to promote capsule expression on the Escherichia
coli surface (Frosch et al. 1989). Besides underlining the effi-
ciency of our screening procedure, this offered a functional
confirmation of the completeness of our library. Regarding
the LOS, the number of genes that can be identified is uncer-
tain because some mutants, for example a mutant in the kdtA
gene (Fig. 3A), are expected to be affected for growth and
therefore probably absent from the library, whereas other mu-
tants may be serum-resistant. This latter hypothesis was con-
firmed by the sequencing program that led to the identifica-
tion of two additional LOS mutants, with insertions in lst and
rfaF genes, which we did not identify during the screening.
Individual analysis confirmed that these genes are dispens-
able for serum-resistance (data not shown). For the lst gene,
which is necessary for LOS sialylation, this is in agreement
with a previous report (Vogel et al. 1999), whereas it is sur-
prising for the rfaF gene, which is supposed to be required for
the synthesis of the LOS (Fig. 3A) (Jennings et al. 1995).
Functional Characterization of the Serum-Sensitive
Mutants with Insertions in New Genes
The most interesting category of mutants contained inser-
tions within four previously uncharacterized genes of highly
probable (NMB0638), possible (NMB0352 and NMB2076), or
unknown function (NMB0065) (Table 2). We investigated the
possibility that these genes too were involved in the synthesis
of capsule and/or LOS by respectively quantifying the amount
of polysialic acid they produced (Fig. 4) using a whole-cell
ELISA assay (Abdillahi and Poolman 1987), and by visualizing
their LOS on SDS-PAGE (Fig. 3B).
Mutants with transposon insertions in NMB0065 and
Figure 2 Survival of N. meningitidis 8013 (triangles) and an isogenic unencapsulated mutant (squares) in native (A) and heat-inactivated serum
(B). Error bars indicate standard errors of the means (n = 4).
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NMB0352 presented a reduced capsule production (Fig. 4),
which suggested that these genes were previously unidenti-
fied determinants of polysialic acid capsule synthesis. The
NMB0065mutant had a dramatically reduced capsule produc-
tion, and can therefore be considered as unencapsulated,
which was confirmed by immunofluorescence microscopy
(data not shown). Interestingly, in the MC58 genome (Tette-
lin et al. 2000), this gene is localized within the cps gene
cluster required for capsule production (Frosch et al. 1989),
and is not found in the Z2491 genome, a strain that does not
produce a polysialic acid capsule. A detailed PSI-BLAST analy-
sis showed that NMB0065, which was annotated as an hypo-
thetical protein (Tettelin et al. 2000), has homologies with
neuE, a gene essential for encapsulation of E. coli K1 (Steen-
bergen et al. 1992). In contrast, the NMB0352 mutant had a
slightly reduced capsule production (Fig. 4), which neverthe-
less makes the corresponding gene the first one involved in
capsule biosynthesis that is not localized in the cps cluster
(Frosch et al. 1989). This gene was predicted to encode a pro-
tein with a domain found in many phosphosugar isomerases
and phosphosugar binding proteins, one of which is interest-
ingly KpsF, a protein of unknown function conserved among
the E. coli group II capsule gene clusters (Simpson et al. 1996).
The two remaining mutants, with transposon insertions
in NMB0638 and NMB2076, presented a truncated LOS (Fig.
3B), which demonstrated that these genes are previously uni-
dentified determinants of LOS biosynthesis. On the basis of
strong sequence homologies, NMB0638 was predicted in the
databases to encode GalU, an enzyme involved in the forma-
tion of UDP-glucose, which is a precursor of the biosynthesis
of LOS (Kahler and Stephens 1998) (Fig. 3A). Accordingly, the
LOS produced by this mutant (Fig. 3B) was as truncated as the
LOS produced by a pgmmutant (Fig. 3B), which is also unable
to synthesize UDP-glucose (Kahler and Stephens 1998). This is
an indirect but strong indication that NMB0638 encodes
GalU. On the other hand, a BLASTP analysis demonstrated
that NMB2076, which was annotated as a possible transferase
from the aut family, is homologous to the domain II of E. coli
RfaE. In E. coli, RfaE is a bifunctional enzyme involved in the
biosynthesis of ADP-L-glycero-D-manno-heptose (Valvano et
al. 2000), another precursor of LOS. This observation was vali-
dated by the fact that the LOS produced by this mutant is
deeply truncated as in other rfa mutants also affected in the
synthesis of the core (Fig. 3B).
DISCUSSION
The release of two genomic sequences (Parkhill et al. 2000;
Tettelin et al. 2000) ushered N. meningitidis into the era of
postgenomics where sequence needs to be turned into func-
tion. A major challenge is to assign, or experimentally con-
firm, a biologic role to a majority of the 2100 meningococcal
predicted coding regions. A powerful method for determining
function being the phenotypic analysis of genome-wide col-
lections of mutants, we aimed at creating such a library in N.
meningitidis. Unfortunately, the two sequenced meningococ-
cus strains are either not (Z2491) or poorly (MC58) transform-
able, and cannot be used for such an approach. Therefore, we
chose N. meningitidis 8013, a serogroup C strain (C:
22:NST:L3,7,9) initially isolated in 1989 from the blood of a
patient, because it is genetically tractable and has been widely
used to study meningococcal biology (Nassif et al. 1993; De-
ghmane et al. 2000). We describe here means for the construc-
tion of a genome-wide library in a reasonable time period,
Table 2. Characteristics of the Serum-Sensitive Mutants Identified in this Study
NMB NMA
Number
of mutants Gene Predicted function in databases S.I.
Capsule biosynthesis genes
0069 1 siaB sialic acid biosynthesis protein 9.20 102
0070 3 siaA sialic acid biosynthesis protein <2.72 107
0071 0198 1 ctrA capsule export outer-membrane protein 9.36 103
0072a 0197 1 ctrB capsule export inner-membrane protein 3.47 104
0073 0196 1 ctrC capsule export inner-membrane protein <2.72 107
0074 0195 2 ctrD capsule export ATP-binding protein 8.34 103
0082 0186 2 lipA capsule phospholipid modification protein <2.72 107
0083 0185 5 lipB capsule phospholipid modification protein <2.72 107
— 1 — siaA-ctrA intergenic region 3.66 104
LOS biosynthesis genes
0790 1001 3 pgm phosphoglucomutase 1.06 103
0825 1034 1 rfaE ADP-heptose synthetase 2.57 102
0828 1037 2 rfaD ADP-L-glycero-D-manno-heptose epimerase 1.39 101
1704 1958 3 lgtF -1,4-glucosyl transferase 8.43 103
1926 0527 1 IgtE latco-N-neotetraose biosynthesis glycosyl transferase 9.00 103
1929 0524 4 lgtA lacto-N-neotetraose biosynthesis glycosyl transferase 3.07 102
—b 1 — region downstream lgtE 1.93 101
New genes
0065 2 hypothetical protein <2.72 107
0352a 2135 1 possible sugar isomerase 4.44 103
0638 0848 1 galU probable UTP-glucose-1-phosphate uridylyltransferase 1.65 102
2076 0356 1 possible transferase (aut family) 8.99 103
NMA and NMB denote the ORFs, in Z2491 and MC58 genomes, respectively, homologous to the sequence flanking the transposon insertion
sites. Number of mutants indicates the number of insertions within a defined gene.
S.I., Survival index defined as the ratio of the number of CFU of mutant to wild type after 5 h in native serum (n = 3).
aThe transposon was inserted in the promoter region of the gene.
bThis mutant presented a truncated LOS, but the affected gene could not be identified using the available sequences.
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which relies, in the first place, on the use of high-density
transposon mutagenesis to create an ordered library of signa-
ture-tagged mutants. We performed in vitro transposition of
Himar1 mariner on N. meningitidis 8013 chromosomal DNA to
construct a library of 4548 viable mutants, organized in pools
of 44–48 mutants that can be assayed simultaneously. This
step is followed, in a second phase, by the sequencing of the
transposon insertion sites in all the mutants. Importantly, we
show that LMPCR (Prod’hom et al. 1998) is a practical means
for this otherwise often limiting step. We present the results
of the sequencing analysis of the first half of the library, cor-
responding to the mutants of the pools 1 to 48. One thousand
eight hundred eighty-six transposon insertion sites, in 83% of
the analyzed mutants, were successfully sequenced. We can
therefore estimate that approximately 3761 insertion sites
could ultimately be sequenced using this reasonably practical
method. If necessary, the sequencing of the remaining inser-
tion sites may be done using conventional methods, usually
more labor-intensive, such as the construction of libraries
containing the junctions between the transposon and the
chromosome, as demonstrated in Mycoplasma (Hutchison et
al. 1999).
Seventeen percent of the sequenced insertion sites could
not be mapped using the available heterologous genome se-
quences. This is consistent with the fact that as much as 17%
of N. meningitidis gene content may be strain-specific (Parkhill
et al. 2000; Tettelin et al. 2000). This makes it clear that the
genome sequence of the target strain is indispensable for an
exhaustive exploitation and precise interpretation of the se-
quencing results, which prompted us to start sequencing the
genome of N. meningitidis 8013 (unpublished data). Neverthe-
less, although it clearly leads to an imperfect estimation of the
efficiency of our approach, the mapping of the insertion sites
on the available sequences demonstrated that transposition
was random. However, it should be pointed out that there was
a substantial bias towards transposition in intergenic regions,
a phenomenom already observed in a similar global transpo-
son mutagenesis approach performed inMycoplasma (Hutchi-
son et al. 1999), which should therefore be taken into account
in the initial calculation. Therefore, when a library of 4500
transposition mutants is available for an organism with a ge-
nome size and coding density similar to N. meningitidis, it can
be estimated that LMPCR may lead to the sequencing of 3721
transposon insertion sites, of which 2642 may be in genes.
This number is high enough to provide an 83% saturation in
nonessential genes (Walbot 2000), which is supported both
by our sequencing data and our functional analysis. There-
fore, the modest increase in saturation expected to result from
the sequencing of the remaining insertion sites, which would
require the use of laborious methods, may not justify such a
profusion of efforts. Instead, it may be preferable to construct
directly the missing mutants, corresponding probably to
small genes that were less likely to be mutagenized.
We illustrated the validity of this resource for functional
genomics, by identifying the genes required for serum-
resistance, a phenotype central to meningococcal virulence
never assayed before by random mutagenesis. Although the
functional analysis of virulence phenotypes in N. meningitidis
is complicated by the fact that the expression of numerous
virulence factors can be switched on and off through changes
in the length of simple DNA repeats (Snyder et al. 2001), the
identification of 37 serum-sensitive mutants confirmed that
this approach is valid. These mutants were characterized for
Figure 3 Functional analysis of LOS mutants. (A) Representation of N. meningitidis 8013 LOS. (B) Silver-stained SDS-PAGE of LOS preparations
with wild-type (WT) included as a control.
Figure 4 Functional analysis of capsule mutants. The amount of
surface-bound capsular polysaccharide relative to the wild-type was
determined by whole-cell ELISA quantitation. Error bars indicate stan-
dard errors of the means (n = 3).
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the synthesis of the polysialic acid capsule and LOS, which
demonstrated that the 18 genes that were disrupted were all
involved in the synthesis of these two molecules. Besides un-
derlining the efficiency of our screening procedure, the iden-
tification of 8 of 10 genes that are necessary for the produc-
tion of the capsule (Frosch et al. 1989) is a functional confir-
mation that our library contains mutants in approximately
80% of meningococcus nonessential genes. It is therefore very
likely that capsule and LOS are the only meningococcal at-
tributes necessary for serum resistance. Furthermore, our
analysis assigned a role in LOS or capsule biosynthesis, the
biosynthesis of which has been extensively studied in the past
13 years, to four previously uncharacterized genes. For ex-
ample, we show that NMB2076 is necessary for the synthesis
of the LOS and presents homologies to domain II of RfaE, the
E. coli ADP-heptose synthetase. Surprisingly, NMB0825,
which was also identified during this analysis, was annotated
as rfaE in the databases (Parkhill et al. 2000; Tettelin et al.
2000). This apparent discrepancy was explained by a detailed
BLASTP analysis that demonstrated that these two proteins
are indeeed homologous to the bifunctional E. coli RfaE en-
zyme (Valvano et al. 2000), but to the first and second do-
main, respectively. This not only shows that the two domains
are genetically separated in N. meningitidis, but also suggests
that the actual ADP-heptose synthetase function, catalyzed by
the second domain of the E. coli RfaE protein, is not encoded
by NMB0825 but rather by NMB2076.
In summary, a large-scale analysis of the N. meningitidis
genome allowed us to revisit serum-resistance, an “old” phe-
notype essential for pathogenicity, and helped us to demon-
strate that we have an extensive ordered collection of menin-
gococcal mutants that is a good starting point for the creation
of a collection containing mutants with insertions in each
nonessential gene. We expect this resource to be valuable for
the production of a global map of gene function, and the
definition of the minimal set of genes necessary for menin-
gococcal life.
METHODS
Bacterial Strains and Growth Conditions
N. meningitidis 8013, a serogroup C strain (C:22:NST:L3,7,9),
was used in this study. As a serum-sensitive control, we used
an unencapsulated siaA isogenic mutant that we generated by
allelic exchange as described (Edwards et al. 1994). N. menin-
gitidis was grown on GCB medium and E. coli was grown on
Luria Bertani medium. When required, kanamycin was added
at 20 and 100 µg/mL for E. coli and N. meningitidis, respec-
tively. Transformation of N. meningitidis was done as previ-
ously described (Pelicic et al. 2000).
Construction of the Library of Mutants
We previously described the mariner-based in vitro transposi-
tion system for N. meningitidis (Pelicic et al. 2000). For this
study, the mini-transposon, which consists of Himar1 in-
verted repeats flanking a kanamycin resistance cassette and a
neisserial uptake sequence, was adapted for STM (Hensel et al.
1995) by cloning 80-bp oligonucleotide signature tags, with
SalI restriction sites at their extremities, within a SalI site in-
ternal to the transposon. Forty-eight tagged transposons, each
labeled with a different signature tag, were selected and used
to produce 48 mutant libraries. Ninety-six mutants of each
library were organized on microtiter plates that were imme-
diately frozen at 80°C in 20% glycerol. This was done in
such a way that the same wells from different microtiter plates
contained different mutants with the same signature tag,
whereas mutants from different wells within the same mi-
crotiter plate harbored different signature tags. This original
library was replicated, and the replica, consisting of 4548 vi-
able mutants, was used throughout this study.
Characterization of Transposon Insertion Sites
The identification of genomic DNA sequences flanking the
inserted transposons was done by LMPCR (Prod’hom et al.
1998) as described (Pelicic et al. 2000). We first prepared chro-
mosomal DNAs for each of the 4548 viable mutants of the
library and ordered them on microtiter plates in the same
order as the corresponding mutants of the original library. To
facilitate the precise identification of the transposon insertion
site, the only change to the published method consisted in
the sequencing with outward-reading primers internal to the
mini-transposon, ISR (5-CGCTCTTGAAGGGAACTATGT
TGA-3) or ISL (5-AATCATTTGAAGGTTGGTACTATA-3), in-
stead of the LMP1 primer located in the linker that was pre-
viously used (Pelicic et al. 2000). Sequence homology searches
were performed using BLASTN against the meningococcal se-
quences present in the databases at TIGR (http://tigrblast.
tigr.org/cmr-blast/) and the Sanger Center (http://www.
sanger.ac.uk/Projects/N_meningitidis/blast_server.shtml).
When searches were positive, there was in general 90%–100%
identity with sequences in the databases, especially in the
immediate vicinity of the insertion. Negative searches did not
return any homologous sequences, indicating that the inser-
tions occurred in regions specific to our target strain. Where
indicated, the corresponding proteins were compared, using
BLASTP and PSI-BLAST programs, with the protein sequences
in the NCBI (http://www.ncbi.nlm.nih.gov/BLAST/) and
PRODOM (http://prodes.toulouse.inra.fr/prodom/2002.1/
html/home.php) databases.
Serum Bactericidal Assays
Blood from several individuals with hereditary haemochro-
matosis, which are treated by frequent phlebotomies (Provan
and Weatherall 2000), was obtained on a regular basis from
Prof. M. Joussemet (Centre de Transfusion Sanguine des Ar-
me´es). The serum from this blood that is otherwise discarded,
was purified by three rounds of centrifugation at 3000 g for
15 min at 4°C, divided into aliquots, and immediately stored
at 80°C. Laboratory tests showed that serum composition
was normal, except for a ferritin concentration of approxi-
mately 2,000 µg/L. Mutants to be tested were grown on GCB
agar plates overnight and colonies were inoculated in 5 mL of
RPMI and grown for 2 h at 37°C. Optical density (OD) was
read at 600 nm and adjusted at 0.1 in RPMI. Serum, RPMI and
bacteria were mixed in four-well NUNC plates (POLYLABO) so
that the final 400 µL suspension contained 2 105 colony-
forming units (CFU) in 25% serum (vol/vol). A control reac-
tion was performed in the same conditions with serum de-
complemented by heating at 56°C for 30 min. The reactions,
performed at least in triplicate, were incubated at 37°C in an
atmosphere containing 5% CO2. Twenty-microliter samples
were taken from the reaction mixtures at different time
points, and serial dilutions were plated on GCB. Colony
counts were performed after overnight incubation of the
plates and the number of CFU was calculated at each sam-
pling time. Data were expressed as a survival index, defined as
the ratio of mutant-to-wild-type CFU at a defined time, cor-
rected by the initial ratio of mutant-to-wild-type CFU.
When pools of mutants were assayed, clones were resus-
pended individually in RPMI on microtitre plates, OD600 was
measured on a microtiter plate reader, and equivalent
amounts of each mutant were pooled. After 2 h of growth at
37°C, the OD600 was measured and adjusted to 0.5 in RPMI.
Serum, RPMI, and bacteria were mixed in four-well NUNC
plates so that the final 400-µL suspension contained 106 CFU
in 25% serum (vol/vol), or approximately 2 104 CFU of
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each mutant. The reactions, performed in duplicate, were in-
cubated at 37°C for 5 h in an atmosphere containing 5% CO2.
We chose a 5-h incubation time to avoid a bias towards the
most serum resistant meningococci being selected, which is
much more likely to happen at shorter incubation times.
More than 104 CFU were collected after overnight incubation
of serial dilutions plated on GCB and subjected to signature
tag amplification.
Signature Tag Manipulation and Hybridization
Chromosomal DNA was prepared from isolated or pooled me-
ningococci using the Wizard Genomic DNA Purification kit
(Promega) following the manufacturer’s recommendations.
Signature tag amplification, labeling, and hybridization were
done as described (Camacho et al. 1999).
Capsule and LOS Analysis
Serogroup C capsular polysaccharide was detected using the
Pastorex Meningitis 61160 kit (Biorad). It was quantified by
whole-cell ELISA as described (Abdillahi and Poolman 1987),
using a serogroup C capsular polysaccharide-specific mouse
serum that was generously donated by M.-J. Quentin-Millet
(Aventis Pasteur). LOS was prepared from standard numbers
of CFU by a proteinase K treatment (Hitchcock and Brown
1983), resolved on 16% tricine SDS-PAGE gels (Lesse et al.
1990), and visualized by silver staining (Tsai and Frasch 1982).
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